Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

INTRODUCTION: Insomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited research on the effects of cannabis on sleep and dayt...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMJ Open
Κύριοι συγγραφείς: Suraev, Anastasia, Grunstein, Ronald R, Marshall, Nathaniel S, D'Rozario, Angela L, Gordon, Christopher J, Bartlett, Delwyn J, Wong, Keith, Yee, Brendon J, Vandrey, Ryan, Irwin, Chris, Arnold, Jonathon C, McGregor, Iain S, Hoyos, Camilla M
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BMJ Publishing Group 2020
Θέματα:
Pharmacology and Therapeutics
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239553/
https://ncbi.nlm.nih.gov/pubmed/32430450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034421
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια